Journal of Clinical Epidemiology
Volume 53, Issue 9 , Pages 931-939 , September 2000

Choice of effect measure for epidemiological data

  • S.D Walter

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel: 905-525-9140, ext. 22338; fax: 905-529-3012.(S.D. Walter)

Received 5 January 1999 ,Revised 11 November 1999 ,Accepted 26 January 2000.

References 

  1. Sackett DL, Cook RJ. Understanding clinical trials. BMJ. 1994;309:755–776
  2. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical trials. Ann Intern Med. 1997;126:712–720
  3. Sinclair JC, Bracken MB. Clinically useful measure of effect in binary analyses of randomized trials. J Clin Epiemiol. 1994;47:881–889
  4. Davies HTO, Crombie IK, Tavakoli M. When can odds ratios mislead?. BMJ. 1998;316:989–991
  5. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1691
  6. Rothwell PM. Can overall results of clinical trials be applied to all patients?. Lancet. 1995;345:1616–1619
  7. Morabia A, Ten Have T, Landis R. Interaction fallacy. J Clin Epidemiol. 1997;50:809–812
  8. Sackett DL. Down with odds ratios!. Evidence-Based Med. 1996;1:164–166
  9. Olkin I. Odds ratios revisited. Evidence-Based Med. 1998;3:71
  10. Senn S. Odds ratios revisited. Evidence-Based Med. 1998;3:71
  11. Walter SD. Odds ratios revisited. Evidence-Based Med. 1998;3:71
  12. Fleiss JL. Measures of effect size for categorical data. In:  Cooper H,  Hedges LV editor. The Handbook of Research Synthesis. New York: Russell Sage; 1994;
  13. Cox DR. Analysis of Binary Data. London: Methuen;; 1970;
  14. Walter SD, Holford TR. Additive, multiplicative and other models of disease risks. Am J Epidemiol. 1978;108:341–346
  15. Sheps MC. Shall we count the living or the dead?. N Engl J Med. 1958;259:1210–1214
  16. Greenland S. Interpretation and choice of effect measures in epidemiologic analyses. Am J Epidemiol. 1987;125:761–768
  17. Sackett DL, Haynes RB, Tugwell P. Clinical Epidemiology. Boston: Little Brown; 1985;
  18. Fleiss JL. On the asserted invariance of the odds ratio. Br J Prev Soc Med. 1970;24:45–46
  19. Lachenbruch PA. The odds ratio. Controlled Clin Trials. 1997;18:381–382
  20. Reid MC, Lane DA, Feinstein AR. Academic calculations versus clinical judgements (practicing physicians' use of quantitative measures of measures of text accuracy). Am J Med. 1998;104(4):374–380[see comments]
  21. Schmid CH, Lau J, Mcintosh MW, Cappelleri JC. An empirical study of the effect of control rate as a predictor of treatment efficacy in meta-analysis of clinical trials. Stat Med. 1998;17:1923–1942
  22. Callas PW, Pastides H, Hosmer DW. Empirical comparisons of proportional hazards, poisson, and logistic regression modeling of occupational cohort data. Am J Ind Med. 1998;33(1):33–47
  23. Thomas DC. General relative-risk models for survival time and matched case-control analysis. Biometrics. 1981;37(4):673–686
  24. Pearce N. What does the odds ratio estimate in a case-control study?. Int J Epidemiol. 1993;22:1189–1192
  25. Armitage P, Doll R. The age distribution of cancer and a multi-stage model of carcinogenesis. Br J Cancer. 1954;8:1–12
  26. Forrow L, Taylor WC, Arnold RM. Absolutely relative (how research results are summarized can affect treatment decisions). Am J Med. 1992;92:121–124
  27. Naylor CD, Chen E, Strauss B. Measured enthusiasm (does the method of reporting trial results alter perceptions of therapeutic effectiveness?). Ann Intern Med. 1992;117:916–921
  28. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ. 1994;309:761–764

PII: S0895-4356(00)00210-9

Journal of Clinical Epidemiology
Volume 53, Issue 9 , Pages 931-939 , September 2000

Article Tools

* Image Usage & Resolution